Cytosorbents (CTSO) Current Leases (2018 - 2026)
Cytosorbents' (CTSO) quarterly Current Leases came in at $589000.0 in Q2 2026, up 18.99% on a YoY basis from $495000.0 in Q2 2025, and up 4.25% quarter-over-quarter from $565000.0 in Q1 2026.
Analysis
Cytosorbents (CTSO) Current Leases (2018 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Current Leases for 9 consecutive years, with $589000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Leases rose 18.99% year-over-year to $589000.0; the trailing twelve-month figure through Jun 2026 stood at $589000.0 (up 18.99% YoY), and the FY2025 full-year result was $541000.0, up 19.43% from the prior year.
- Current Leases grew to $589000.0 in Q2 2026 per CTSO's latest filing, from $565000.0 in the prior quarter.
- Across five years, Current Leases topped out at $589000.0 in Q2 2026 and bottomed at $108939.0 in Q4 2022.
- Historically, Current Leases has averaged $387650.7 across 5 years, with a median of $424429.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Current Leases slumped 80.91% in 2022, then soared 268.59% in 2024.
- Over 5 years, Current Leases stood at $108939.0 in 2022, then jumped by 242.98% to $373636.0 in 2023, then climbed by 21.24% to $453000.0 in 2024, then grew by 19.43% to $541000.0 in 2025, then climbed by 8.87% to $589000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $589000.0, $565000.0, and $541000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 24.10 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 81.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 20.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 589,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 589,000.00 |
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 541,000.00 |
| Sep 30, 2025 | 518,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 473,889.00 |
| Dec 31, 2024 | 453,000.00 |
| Sep 30, 2024 | 431,997.00 |
| Jun 30, 2024 | 412,067.00 |
| Mar 31, 2024 | 392,617.00 |
| Dec 31, 2023 | 373,636.00 |
| Sep 30, 2023 | 117,204.00 |
| Jun 30, 2023 | 114,382.00 |
| Mar 31, 2023 | 111,627.00 |
| Dec 31, 2022 | 108,939.00 |
| Sep 30, 2022 | 376,529.00 |
| Jun 30, 2022 | 416,861.00 |
| Mar 31, 2022 | 486,964.00 |
| Dec 31, 2021 | 570,566.00 |
| Sep 30, 2021 | 265,675.00 |